📈 Live Market Tracking
AI-Powered NSE Corporate Announcements Analysis
Vidhi Specialty 9M FY26 PAT Rises 13.6% to ₹35.8 Cr; EBITDA Margins Expand to 22.3%
Vidhi Specialty Food Ingredients reported a resilient performance for 9M FY26, with PAT growing 13.6% YoY to ₹35.8 crore despite a 5.7% decline in revenue to ₹257.3 crore. The company is successfully transitioning its business model from low-margin trading to high-margin manufacturing, which led to a significant EBITDA margin expansion from 17.7% to 22.3%. Capacity expansion is a key growth driver, with the Dahej plant (350 MT) now operational and the Roha Phase II expansion (350 MT) on track to reach a total capacity of 1,000 TPM by 2025-26. Financial health remains robust with a low debt-to-equity ratio of 0.20.
Key Highlights
9M FY26 EBITDA increased by 18.8% YoY to ₹57.4 crore with margins improving by 460 bps to 22.3%.
Phase I Dahej SEZ plant (350 MT) successfully commenced production, increasing total capacity to 675 TPM.
Phase II Roha expansion (350 MT) is in progress with an expected completion timeline of 2025-26.
9M FY26 PAT stood at ₹35.8 crore, up 13.6% YoY, although Q3 FY26 PAT saw a minor 2.5% dip due to lower exchange gains.
Maintains a strong balance sheet with a healthy Debt-to-Equity ratio of 0.20.
💼 Action for Investors
Investors should monitor the utilization levels of the new Dahej facility and the progress of the Roha Phase II expansion. The structural shift toward higher-margin manufactured products makes the company a strong candidate for long-term growth in the specialty chemicals space.
Vidhi Specialty Food Ingredients Q3 FY26 Results Approved; No 3rd Interim Dividend Declared
Vidhi Specialty Food Ingredients approved its un-audited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025. The board meeting, held on February 02, 2026, also reviewed the Limited Review Report for the same period. A significant update for shareholders is the board's decision to skip the declaration of a third interim dividend for the 2025-26 fiscal year. Investors should now look for the detailed profit and loss statements to evaluate operational performance.
Key Highlights
Approval of un-audited standalone and consolidated financial results for the quarter ended December 31, 2025.
Board of Directors officially decided not to declare a 3rd interim dividend for the financial year 2025-26.
Limited Review Reports for the nine-month period were taken on record by the board.
The board meeting was conducted and concluded within a one-hour timeframe on February 02, 2026.
💼 Action for Investors
Investors should examine the detailed financial tables to assess revenue and margin trends. The decision to skip the third interim dividend suggests the company may be prioritizing cash conservation for capital expenditure or debt management.